Servier Completes the Acquisition of Symphogen
PARIS, June 4, 2020 /PRNewswire-AsiaNet/ -- Servier, an independent international pharmaceutical company, today announced that it has completed the acquisition of Symphogen A/S.Symphogen will now function as Servier’s antibody center of excellence across multiple different therapeutic a...
Authors: LATEST ASIANET NEWS RELEASES